AI Search

Research Assistant

Search across all peptide monographs, dosing protocols, and clinical articles. Type a keyword to find relevant information instantly.

24 items available — type to search

PeptideGrowth Hormone Fragment / Lipolytic Peptide · Fat reduction and body composition improvement (investigational; no regulatory approval for therapeutic use)

AOD-9604

Growth Hormone Fragment - Fat Metabolism Guide

PeptideCytoprotective Pentadecapeptide · Gastrointestinal cytoprotection and mucosal healing (investigational)

BPC-157

Body Protection Compound - Complete Clinical Guide

PeptideGHRH Analog + Growth Hormone Secretagogue (GHS) Combination · Growth hormone deficiency and age-related GH decline (investigational combination)

CJC-1295/Ipamorelin

Growth Hormone Secretagogue Combination - Prescriber Guide

PeptideSynthetic Tetrapeptide (Pineal Gland Bioregulator) · Telomerase activation and telomere maintenance (investigational anti-aging peptide)

Epithalon

Telomerase Activator Peptide - Anti-Aging Guide

PeptideCopper-Binding Tripeptide (Endogenous Regenerative Peptide) · Wound healing and tissue repair (topical and injectable formulations)

GHK-Cu

Copper Peptide Complex - Regenerative Medicine Guide

PeptideMelanocortin Receptor Agonist (Cyclic Heptapeptide) · Hypoactive sexual desire disorder (HSDD) in premenopausal women (FDA-approved as Vyleesi)

PT-141 (Bremelanotide)

Melanocortin Receptor Agonist - Sexual Dysfunction Guide

PeptideSynthetic Tuftsin Analog / Anxiolytic-Nootropic Peptide · Generalized anxiety disorder and neurasthenia (approved in Russia as intranasal spray)

Selank

Synthetic tuftsin-analog heptapeptide with anxiolytic, nootropic, and immunomodulatory properties

PeptideGLP-1 Receptor Agonist (Incretin Mimetic) · Type 2 diabetes mellitus (FDA-approved: Ozempic, Rybelsus) and chronic weight management (FDA-approved: Wegovy)

Semaglutide

GLP-1 Receptor Agonist - Prescriber Reference

PeptideGrowth Hormone-Releasing Hormone (GHRH) Analog / GH Secretagogue · Growth hormone optimization and anti-aging (off-label via compounding pharmacies)

Sermorelin

Synthetic GHRH(1-29) fragment for physiologic growth hormone optimization

PeptideActin-Sequestering / Regenerative Peptide · Wound healing and tissue repair (investigational; pharmaceutical Tbeta4 in Phase II trials for epidermolysis bullosa and dry eye)

TB-500

Thymosin Beta-4 Fragment - Tissue Repair Guide

PeptideSynthetic GHRH Analog (Growth Hormone-Releasing Hormone) · Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy (FDA-approved)

Tesamorelin

GHRH Analog - FDA-Approved Growth Hormone Secretagogue

PeptideImmune-Modulating Thymic Peptide · Chronic hepatitis B (approved in 35+ countries as Zadaxin); immune modulation (compounded use in US)

Thymosin Alpha-1

Immune-Modulating Peptide - Clinical Monograph

PeptideDual GIP/GLP-1 Receptor Agonist (Twincretin) · Type 2 diabetes mellitus (FDA-approved: Mounjaro, 2022) and chronic weight management (FDA-approved: Zepbound, 2023; expanded in 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity)

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist - Clinical Guide

Protocol300mcg/day · 12-24 weeks

AOD-9604 — Fat loss / Body composition

Fat loss / Body composition

Protocol250mcg/day · 4-8 weeks

BPC-157 — Gut healing

Gut healing

Protocol250mcg/day · 6-12 weeks

BPC-157 — Injury repair / Musculoskeletal

Injury repair / Musculoskeletal

Protocol100mcg each · Ongoing (cycle 3-6 months on, 1 month off)

Ipamorelin/CJC-1295 — Anti-aging / GH optimization

Anti-aging / GH optimization

ProtocolPRN (as needed) · As needed

PT-141 (Bremelanotide) — Sexual dysfunction

Sexual dysfunction

ProtocolUp to 2.4mg/week · Ongoing

Semaglutide — Weight loss / Obesity

Weight loss / Obesity

Protocol2.5mg weekly · 4-6 weeks loading, then maintenance

TB-500 — Tissue repair / Wound healing

Tissue repair / Wound healing

Protocol2mg/day · 26 weeks (FDA-approved course)

Tesamorelin — Lipodystrophy / Visceral fat reduction

Lipodystrophy / Visceral fat reduction

BlogClinical Education · 8 min read · 2024-12-15

Understanding Peptide Therapy: A Clinical Overview for Prescribers

A comprehensive introduction to peptide therapeutics, their mechanisms of action, and clinical considerations for integration into practice.

BlogRegulatory · 10 min read · 2024-12-10

Regulatory Landscape: What Prescribers Need to Know About Compounded Peptides

Navigate the complex regulatory environment surrounding compounded peptides, including FDA guidelines, state requirements, and best practices for compliance.

BlogClinical Practice · 7 min read · 2024-12-05

Patient Selection Criteria for Peptide Therapy

Evidence-based guidance on identifying appropriate candidates for peptide therapeutics, including assessment protocols and contraindication screening.

Medical Disclaimer

This search tool is provided as an educational resource for healthcare professionals. Search results are drawn from curated clinical content and should not replace professional medical judgment. Always verify information with primary sources and current clinical guidelines.